https://www.globenewswire.com/news-release/2021/05/26/2236023/0/en/OSE-Immunotherapeutics-Announces-Dosing-of-the-First-Healthy-Volunteer-in-Phase-1-Clinical-Trial-of-its-Multi-Variant-Second-Generation-COVID-19-Vaccine.html